AGAndre Gosselink

Andre Gosselink

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andre Gosselink has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    InspectorCell: Finding Ground Truth in Multiplexed Microscopy Images

    by Andre Gosselink, Tatsiana Hofer, Elvira Criado-Moronati, Arndt von Haeseler, Jutta Kollet

    Multiplexed immunofluorescence microscopy gives deep insights into biological samples, like cancer tissues. The image intensities reflect the expression of immunological markers on the surfaces of cells that make up the tissue. Typical tasks in analyzing such images are segmenting cells and quantifying their cell surface markers. Novel microscopy methods generate large datasets with hundreds of images per biological sample. The analysis of such large datasets can only be performed using automation, nowadays by machine learning. However, training models for segmentation and quantification require high-quality labeled datasets. Moreover, with recent increases in image stack sizes, the generation of labeled datasets for machine learning has become a significant bottleneck. InspectorCell alleviates this bottleneck by providing an intuitive, graphical interface for synchronized manual segmentation and annotation of cells in highly multiplexed microscopy images. The modular implementation of InspectorCell in Python enables tight integration into existing applications such as Orange3 or CellProfiler. An image dataset with exemplary annotations

  • Open Access

    Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells

    by Niels Werchau, Bettina Kotter, Elvira Criado-Moronati, Andre Gosselink, Nicole Cordes, Dominik Lock, Simon Lennartz, Carolin Kolbe, Nora Winter, Karin Teppert, et al.

    Solid tumors consist of malignant and nonmalignant cells that together create the local tumor microenvironment (TME). Additionally, the TME is characterized by the expression of numerous soluble factors such as TGF-β. TGF-β plays an important role in the TME by suppressing T cell effector function and promoting tumor invasiveness. Up to now CAR T cells exclusively target tumor-associated antigens (TAA) located on the cell membrane. Thus, strategies to exploit soluble antigens as CAR targets within the TME are needed. This study demonstrates a novel approach using Adapter CAR (AdCAR) T cells for the detection of soluble latent TGF-β within the TME of a pancreatic tumor model. We show that AdCARs in combination with the respective adapter can be used to sense soluble tumor-derived latent TGF-β, both in vitro and in vivo. Sensing of the soluble antigen induced cellular activation and effector cytokine production in AdCAR T cells. Moreover, we evaluated AdCAR T cells for the combined targeting of soluble latent TGF-β and tumor cell killing by targeting CD66c as TAA in vivo. In sum, our study broadens the spectrum of targetable moieties for AdCAR T cells by soluble latent TGF-β.